Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
SUMATRIPTAN
Medication labelWhy this: Advisory · dailymed-prescription
Sumatriptan tablets, USP are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan tablets, USP, reconsider the diagnosis of migraine before sumatriptan tablets, USP are administered to treat any subsequent attacks. Sumatriptan tablets, USP are not indicated for the prevention of migraine attacks. Safety and effectiveness of sumatriptan tablets, USP have not been established for cluster headache.
- generic_name
- sumatriptan
- product_names
- SUMATRIPTAN
- ndc
- 61919-950, 65862-146, 61919-950-09
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en